HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it

Cervical cancer remains a leading cause of morbidity and mortality amongst females in Latin America (LATAM). Cervical cancer is a preventable disease and HPV vaccination is a main key strategy towards its elimination. This study analyzes HPV vaccine implementation current status and the main barrier...

Full description

Bibliographic Details
Main Authors: Angélica Nogueira-Rodrigues, Matheus Gonçalves Flores, Avelar Oliveira Macedo Neto, Lucélia Antunes Coutinho Braga, Carolina Martins Vieira, Renata Maria de Sousa-Lima, Diocésio Alves Pinto de Andrade, Karime Kalil Machado, Andrea Paiva Gadelha Guimarães
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.984449/full
_version_ 1811244811447959552
author Angélica Nogueira-Rodrigues
Matheus Gonçalves Flores
Avelar Oliveira Macedo Neto
Lucélia Antunes Coutinho Braga
Carolina Martins Vieira
Renata Maria de Sousa-Lima
Diocésio Alves Pinto de Andrade
Karime Kalil Machado
Andrea Paiva Gadelha Guimarães
author_facet Angélica Nogueira-Rodrigues
Matheus Gonçalves Flores
Avelar Oliveira Macedo Neto
Lucélia Antunes Coutinho Braga
Carolina Martins Vieira
Renata Maria de Sousa-Lima
Diocésio Alves Pinto de Andrade
Karime Kalil Machado
Andrea Paiva Gadelha Guimarães
author_sort Angélica Nogueira-Rodrigues
collection DOAJ
description Cervical cancer remains a leading cause of morbidity and mortality amongst females in Latin America (LATAM). Cervical cancer is a preventable disease and HPV vaccination is a main key strategy towards its elimination. This study analyzes HPV vaccine implementation current status and the main barriers to achieve adequate coverage in the region. Data from the nineteen sovereign states of LATAM (comprised of all Portuguese and Spanish-speaking nations located south of the United States) were collected, including year of HPV vaccine implementation, gender and age targets, the number of doses included in the public program and coverage by dose. Sixteen out of the 19 evaluated countries have already implemented HPV vaccination programs. However, despite its proven efficacy and safety, HPV vaccine uptake in LATAM has been lower than expected. There is an evident decline in adhesion, mainly regarding the second dose. Several reasons are probably involved, of note: limited knowledge of HPV and HPV vaccine, misguided safety concerns, high cost, cultural barriers, and the Covid19 pandemic. Proper strategies to overcome these barriers are needed to ensure successful uptake. Effective policies are: adopting the one dose schedule, delivering the vaccine on both health center and schools, and advising health professionals to recommend the vaccine. Further research regarding HPV vaccine hesitancy in Latin America is needed.
first_indexed 2024-04-12T14:31:20Z
format Article
id doaj.art-381e89a8a5034585ada0290eae9025b7
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T14:31:20Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-381e89a8a5034585ada0290eae9025b72022-12-22T03:29:16ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.984449984449HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome itAngélica Nogueira-Rodrigues0Matheus Gonçalves Flores1Avelar Oliveira Macedo Neto2Lucélia Antunes Coutinho Braga3Carolina Martins Vieira4Renata Maria de Sousa-Lima5Diocésio Alves Pinto de Andrade6Karime Kalil Machado7Andrea Paiva Gadelha Guimarães8Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizontel, BrazilFederal University of Minas Gerais, Belo Horizontel, BrazilFederal University of Minas Gerais, Belo Horizontel, BrazilFundação Oswaldo Cruz (FIOCRUZ) Minas, Belo Horizontel, BrazilClinical Oncologist at Oncoclinicas, Belo Horizontel, BrazilClinical Oncologist at Oncoclinicas, Belo Horizontel, BrazilBrazilian Gynecologic Oncology Group, EVA, São Paulo, BrazilBrazilian Gynecologic Oncology Group, EVA, São Paulo, BrazilBrazilian Gynecologic Oncology Group, EVA, São Paulo, BrazilCervical cancer remains a leading cause of morbidity and mortality amongst females in Latin America (LATAM). Cervical cancer is a preventable disease and HPV vaccination is a main key strategy towards its elimination. This study analyzes HPV vaccine implementation current status and the main barriers to achieve adequate coverage in the region. Data from the nineteen sovereign states of LATAM (comprised of all Portuguese and Spanish-speaking nations located south of the United States) were collected, including year of HPV vaccine implementation, gender and age targets, the number of doses included in the public program and coverage by dose. Sixteen out of the 19 evaluated countries have already implemented HPV vaccination programs. However, despite its proven efficacy and safety, HPV vaccine uptake in LATAM has been lower than expected. There is an evident decline in adhesion, mainly regarding the second dose. Several reasons are probably involved, of note: limited knowledge of HPV and HPV vaccine, misguided safety concerns, high cost, cultural barriers, and the Covid19 pandemic. Proper strategies to overcome these barriers are needed to ensure successful uptake. Effective policies are: adopting the one dose schedule, delivering the vaccine on both health center and schools, and advising health professionals to recommend the vaccine. Further research regarding HPV vaccine hesitancy in Latin America is needed.https://www.frontiersin.org/articles/10.3389/fonc.2022.984449/fullHPVvaccineLatin Americacoveragecervical cancerimplementation
spellingShingle Angélica Nogueira-Rodrigues
Matheus Gonçalves Flores
Avelar Oliveira Macedo Neto
Lucélia Antunes Coutinho Braga
Carolina Martins Vieira
Renata Maria de Sousa-Lima
Diocésio Alves Pinto de Andrade
Karime Kalil Machado
Andrea Paiva Gadelha Guimarães
HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
Frontiers in Oncology
HPV
vaccine
Latin America
coverage
cervical cancer
implementation
title HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
title_full HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
title_fullStr HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
title_full_unstemmed HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
title_short HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it
title_sort hpv vaccination in latin america coverage status implementation challenges and strategies to overcome it
topic HPV
vaccine
Latin America
coverage
cervical cancer
implementation
url https://www.frontiersin.org/articles/10.3389/fonc.2022.984449/full
work_keys_str_mv AT angelicanogueirarodrigues hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT matheusgoncalvesflores hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT avelaroliveiramacedoneto hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT luceliaantunescoutinhobraga hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT carolinamartinsvieira hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT renatamariadesousalima hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT diocesioalvespintodeandrade hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT karimekalilmachado hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit
AT andreapaivagadelhaguimaraes hpvvaccinationinlatinamericacoveragestatusimplementationchallengesandstrategiestoovercomeit